Trump administration strikes deal with AbbVie to cut costs of certain drugs [CNN]
AbbVie Inc. (ABBV)
Last abbvie inc. earnings: 5/1 07:43 am
Check Earnings Report
US:NYSE Investor Relations:
investors.abbvie.com/investor-overview
Company Research
Source: CNN
Under the agreement, AbbVie said Monday it will offer a series of drugs to Medicaid as well as directly to consumers at “Most Favored Nation” levels, or the lowest price available in peer countries. It will sell some other medications at a deep discount compared to their list prices. The drugs subject to “Most Favored Nation” pricing include glaucoma treatment Combigan and thyroid hormone medicine Synthroid. AbbVie is separately expected to reduce the price of its popular rheumatoid arthritis drug Humira, as well as another glaucoma medicine, Alphagan. AbbVie declined to disclose the specifics of the discounts it plans to offer for the drugs. The deal represents the latest in a string of administration pacts with major pharmaceutical companies aimed at lowering the price of drugs, as President Donald Trump tries to assuage voters' concerns over the cost of living. Trump has touted the “Most Favored Nation” initiative as a centerpiece of his health care agenda, vowing to push
Show less
Read more
Impact Snapshot
Event Time:
ABBV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABBV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABBV alerts
High impacting AbbVie Inc. news events
Weekly update
A roundup of the hottest topics
ABBV
News
- Top Research Reports for AbbVie, Intel & Boeing [Yahoo! Finance]Yahoo! Finance
- AbbVie (NYSE:ABBV) had its "neutral" rating reaffirmed by analysts at UBS Group AG.MarketBeat
- JPM26: J&J leans on immunology launches to fuel annual growth [Yahoo! Finance]Yahoo! Finance
- AbbVie and Trump Administration Reach Agreement to Improve Access and Affordability for Americans [Yahoo! Finance]Yahoo! Finance
- AbbVie and Trump Administration Reach Agreement to Improve Access and Affordability for AmericansPR Newswire
ABBV
Earnings
- 10/31/25 - Beat
ABBV
Sec Filings
- 1/7/26 - Form 8-K
- 1/5/26 - Form 4
- 1/5/26 - Form 4
- ABBV's page on the SEC website